Medical Equipment, Supplies & Distribution
Easywell Biomedical Inc:To invest 6 million yuan to set up a 80 pct owned company in Dongguan, which to be engaged in production of temperature measurement products.
Kawanishi Holdings Inc:To establish a wholly owned subsidiary based in Tokyo on Jan. 27, 2016.New subsidiary to be engaged in import and export sale of medical equipment.New subsidiary to be capitalized at 75 million yen.
Jiangxi Sanxin Medtec Co Ltd:To invest 10 million yuan to set up a medical apparatus and instruments wholly owned subsidiary in Nanchang.
Ningbo MedicalSystem Biotechnology Co Ltd:An U.S-based subsidiary SD MEDICAL SYSTEM,INC. to invest $30 million to set up a wholly owned finance lease subsidiary in Ningbo.
Shinva Medical Instrument Co Ltd:To invest 35 mln yuan to set up a wholly owned biotechnology subsidiary in Shandong.To invest $0.5 mln to set up a wholly owned subsidiary in Hong Kong.Wholly owned Shandong-based medical system subsidiary to acquire 94.44 pct stake in a Beijing-based medical supplies company from a Beijing-based investment holding company at price of 11.19 mln yuan.Says to invest 62 mln yuan to set up joint venture in Shandong with United Orthopedic Corporation, for research, development, production and sale of orthopaedics instrument, and JV with registered capital of 200 mln yuan.
HANS BIOMED CORP:Amends transaction settlement date of establish a new wholly owned subsidiary in China, to Dec. 31 from Oct. 30.
Lepu Medical Technology (Beijing) Co Ltd:Completed to set up a Shenzhen-based financial holding wholly owned subsidiary.Completed to set up a Shenzhen-based industrial investment fund management subsidiary and a Shenzhen-based insurance broker subsidiary under the Shenzhen-based financial holding subsidiary.
Lepu Medical Technology (Beijing) Co Ltd:Shenzhen-based financial subsidiary to set up a wholly owned insurance brokering subsidiary in Shenzhen, with capital of 20 mln yuan.
Lepu Medical Technology (Beijing) Co Ltd:Shenzhen-based financial subsidiary to set up a wholly owned fund management subsidiary in Shenzhen, with capital of 50 mln yuan.